CARCINOEMBRYONIC ANTIGEN (CEA) MONITORING IN THE MANAGEMENT OF RADIOTHERAPEUTIC AND CHEMOTHERAPEUTIC PATIENTS

We have measured serial carcinoembryonic antigen (CEA) titers in 122 radiotherapy and 52 chemotherapy patients, randomly selected from the patient population of a Radiotherapeutic and a Cancer Chemotherapy Clinic, and correlated with the clinical and follow-up evaluation. Seventy-eight the radiother...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of roentgenology (1976) Vol. 124; no. 4; pp. 630 - 635
Main Authors:	VIDER, MANUEL, KASHMIRI, RAFIAH, MEEKER, WILLIAM R, MOSES, BERNARD, MARUYAMA, YOSH
Format:	Journal Article
Language:	English
Published:	United States Am Roentgen Ray Soc 01-08-1975
Subjects:	Antigens, Neoplasm Azacitidine - therapeutic use Carcinoembryonic Antigen - analysis Dacarbazine - therapeutic use Fluorouracil - therapeutic use Humans Monitoring, Physiologic Neoplasms - drug therapy Neoplasms - immunology Neoplasms - radiotherapy Neoplasms - therapy Radioisotope Teletherapy
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	We have measured serial carcinoembryonic antigen (CEA) titers in 122 radiotherapy and 52 chemotherapy patients, randomly selected from the patient population of a Radiotherapeutic and a Cancer Chemotherapy Clinic, and correlated with the clinical and follow-up evaluation. Seventy-eight the radiotherapeutic patients had detectable CEA levels which represents the majority of these proven cancer patients. In this group, 57 patients (73 per cent) showed correlation between the curves of CEA response and clinical evaluation diseases activity in the radiotherapy group. Thirty-one of 52, or 60 per cent of patients of the chemotherapy group showed correlation between CEA and clinical response. These data indicate that CEA serum levels parallel, in general, clinical tumor reponse.
ISSN:	0361-803X 0002-9580 1546-3141
DOI:	10.2214/ajr.124.4.630